person · Reporting owner

Dyckerhoff Stefan A

Disclosed activity across 7 companies

Tapewire entity: 2462
SEC CIK: 0001484394

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Astera Labs, Inc.ALAB · Entity 1853	Director	October 01, 2026	October 09, 2026
Everpure, Inc.PSTG · Entity 3140	10% owner	January 11, 2018	January 12, 2018
Mattersight CorpMATR · Entity 164107	10% owner	May 31, 2017	June 02, 2017
Snowflake Inc.SNOW · Entity 2425	10% owner	September 18, 2020	September 22, 2020
Venus Concept Inc.HAIR · Entity 55304	10% owner	October 16, 2017	October 18, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Astera Labs, Inc.

Report date October 01, 2026 · Filed October 09, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	47,019	Last balance in matching sequence After 2026-10-07 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-10-01 · Grant · Acquired 68 · Balance 50,524 F1: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. F2: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Row 2 · 2026-10-07 · Sale · Disposed 3,505 · Balance 47,019 F3: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.
Common StockSEC Table I · non-derivative	IndirectBy Trust	286,400	Reported balance After 2026-10-07 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2026-10-07 · Sale · Disposed 8,333 · Balance 286,400 F3: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Limited Partnership (TF)	2,648	Reported balance After 2026-10-07 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2026-10-07 · Sale · Disposed 661 · Balance 2,648 F3: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F5: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy DIFT-2	3,767	Reported balance Holding disclosure · report date 2026-10-01 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 3,767 F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy DIFT-AMD	3,765	Reported balance Holding disclosure · report date 2026-10-01 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 3,765 F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy DIFT-BAD	3,765	Reported balance Holding disclosure · report date 2026-10-01 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 3,765 F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy DIFT-SHD	3,765	Reported balance Holding disclosure · report date 2026-10-01 · row 8 Holding and transaction disclosures are not merged. 1 source row Row 8 · Balance 3,765 F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy DIFT-IND	3,765	Reported balance Holding disclosure · report date 2026-10-01 · row 9 Holding and transaction disclosures are not merged. 1 source row Row 9 · Balance 3,765 F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

F2: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

F3: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.

F4: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

F5: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

F6: Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

Everpure, Inc.

Report date January 11, 2018 · Filed January 12, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy Trust (Trustees)	0	Last balance in matching sequence After 2018-01-11 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2018-01-11 · Conversion · Acquired 25,520 · Balance 25,520 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 2 · 2018-01-11 · Sale · Disposed 25,520 · Balance 0 F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.73 to $16.835, inclusive. The reporting person undertakes to provide to Pure Storage, Inc., and any security holder of Pure Storage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Trust (Trustees)	242,808	Reported balance After 2018-01-11 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-01-11 · Conversion · Disposed 25,520 · Balance 242,808 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	Direct	14,444	Reported balance Holding disclosure · report date 2018-01-11 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 14,444 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Ltd Liability Company (SHA)	1,024,538	Reported balance Holding disclosure · report date 2018-01-11 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 1,024,538 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F4: Shares held by Sutter Hill Associates, LLC ("SHA"). Sutter Hill Ventures, a California Limited Partnership ("SHV") has voting and dispositive power over the shares held by SHA, and the reporting person is a trustee of a trust which is a member of SHA. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Ltd Liability Company (SHM)	77,100	Reported balance Holding disclosure · report date 2018-01-11 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 77,100 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F5: Shares held by Sutter Hill Management Company, L.L.C ("SHM"). SHV has voting and dispositive power over the shares held by SHM, and the reporting person is a trustee of a trust which is a member of SHM. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV As Nominee)	255,000	Reported balance Holding disclosure · report date 2018-01-11 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 255,000 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F6: Shares held by SHV as a nominee on behalf of, and for the exclusive benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	17,102,128	Reported balance Holding disclosure · report date 2018-01-11 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 17,102,128 F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025. F7: Excludes shares of Class B Common Stock held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner of SHV. F8: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Class B Common Stock is convertible at any time at the option of the reporting person into one share of Class A Common Stock and has no expiration date. The Class B Common Stock will convert automatically into Class A Common Stock on the same basis upon the earlier of: (i) any transfer, whether or not for value, except for certain "Permitted Transfers" as defined in the Issuer's restated certificate of incorporation in effect as of the date hereof, (ii) the affirmative vote of the holders of Class B Common Stock representing not less than a majority of the outstanding shares of Class B Common Stock, or (iii) October 6, 2025.

F2: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.73 to $16.835, inclusive. The reporting person undertakes to provide to Pure Storage, Inc., and any security holder of Pure Storage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Shares held by Sutter Hill Associates, LLC ("SHA"). Sutter Hill Ventures, a California Limited Partnership ("SHV") has voting and dispositive power over the shares held by SHA, and the reporting person is a trustee of a trust which is a member of SHA. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F5: Shares held by Sutter Hill Management Company, L.L.C ("SHM"). SHV has voting and dispositive power over the shares held by SHM, and the reporting person is a trustee of a trust which is a member of SHM. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F6: Shares held by SHV as a nominee on behalf of, and for the exclusive benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F7: Excludes shares of Class B Common Stock held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner of SHV.

F8: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Mattersight Corp

Report date May 31, 2017 · Filed June 02, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Ltd Partnership (SHV)	1,056,194	Last balance in matching sequence After 2017-06-01 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2017-05-31 · Other · Disposed 271,391 · Balance 852,651 F1: On May 31, 2017, a limited partner (the "Limited Partner") of Sutter Hill Ventures, a California Limited Partnership ("SHV") liquidated its interest in SHV in return for its ratable share of the holdings of SHV, resulting in SHV's disposition to the Limited Partner of 271,391 shares (the "Distributed Common Shares") of the Issuer's common stock (the "Liquidation"). F2: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 2 · 2017-06-01 · Purchase · Acquired 203,543 · Balance 1,056,194 F3: In connection with the Liquidation, SHV entered into an agreement with the Limited Partner to repurchase 203,543 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017. F2: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Trust (Trustees)	22,053	Reported balance After 2017-06-01 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-06-01 · Purchase · Acquired 902 · Balance 22,053 F4: In connection with the Liquidation, the reporting person entered into an agreement with the Limited Partner to repurchase 902 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017. F5: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Filing footnotes · ownership attribution and instrument terms

F1: On May 31, 2017, a limited partner (the "Limited Partner") of Sutter Hill Ventures, a California Limited Partnership ("SHV") liquidated its interest in SHV in return for its ratable share of the holdings of SHV, resulting in SHV's disposition to the Limited Partner of 271,391 shares (the "Distributed Common Shares") of the Issuer's common stock (the "Liquidation").

F2: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F3: In connection with the Liquidation, SHV entered into an agreement with the Limited Partner to repurchase 203,543 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017.

F4: In connection with the Liquidation, the reporting person entered into an agreement with the Limited Partner to repurchase 902 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017.

F5: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Snowflake Inc.

Report date September 18, 2020 · Filed September 22, 2020

Security / award	Ownership account	Disclosure context
Series A Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2020-09-18 · Conversion · Disposed 7,822,231 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2020-09-18 · Conversion · Disposed 4,163,543 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2020-09-18 · Conversion · Disposed 7,464,467 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series D Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2020-09-18 · Conversion · Disposed 2,170,228 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series E Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2020-09-18 · Conversion · Disposed 69,370 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series F Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-09-18 · Conversion · Disposed 2,726,595 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series G-1 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2020-09-18 · Conversion · Disposed 727,185 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series Seed Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	Reported balance After 2020-09-18 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2020-09-18 · Conversion · Disposed 2,121,351 · Balance 0 F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock, and Series G-1 Preferred Stock automatically converted into one share of Class B Common Stock immediately upon the closing of the Issuer's initial public offering (IPO), and had no expiration date.

F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Venus Concept Inc.

Report date October 16, 2017 · Filed October 18, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Ltd Partnership (SHV)	2,079,590	Last balance in matching sequence After 2017-10-16 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2017-10-16 · Conversion · Acquired 888,690 · Balance 888,690 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 2 · 2017-10-16 · Conversion · Acquired 606,386 · Balance 1,495,076 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 3 · 2017-10-16 · Conversion · Acquired 479,145 · Balance 1,974,221 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 4 · 2017-10-16 · Conversion · Acquired 105,369 · Balance 2,079,590 F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Trust	18,686	Last balance in matching sequence After 2017-10-16 transaction · row 8 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 5 · 2017-10-16 · Conversion · Acquired 8,882 · Balance 8,882 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 6 · 2017-10-16 · Conversion · Acquired 4,948 · Balance 13,830 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 7 · 2017-10-16 · Conversion · Acquired 3,910 · Balance 17,740 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 8 · 2017-10-16 · Conversion · Acquired 946 · Balance 18,686 F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $7.00	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2017-10-16 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2017-10-16 · Conversion · Disposed 105,369 · Balance 0 F4: This reported amount represents the number of shares issuable upon the conversion of the principal and accrued interest of the convertible promissory note held by the reporting person. F5: The outstanding principal and accrued interest of the reporting person's convertible promissory note automatically converted into shares of the issuer's common stock at the price per share available to the public as set forth in the final prospectus related to the initial public offering upon closing of the initial public offering. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2017-10-16 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2017-10-16 · Conversion · Disposed 479,145 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2017-10-16 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-10-16 · Conversion · Disposed 606,386 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2017-10-16 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-10-16 · Conversion · Disposed 888,690 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $7.00	IndirectBy Trust	0	Reported balance After 2017-10-16 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2017-10-16 · Conversion · Disposed 946 · Balance 0 F4: This reported amount represents the number of shares issuable upon the conversion of the principal and accrued interest of the convertible promissory note held by the reporting person. F5: The outstanding principal and accrued interest of the reporting person's convertible promissory note automatically converted into shares of the issuer's common stock at the price per share available to the public as set forth in the final prospectus related to the initial public offering upon closing of the initial public offering. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2017-10-16 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2017-10-16 · Conversion · Disposed 3,910 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2017-10-16 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2017-10-16 · Conversion · Disposed 4,948 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series C Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2017-10-16 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2017-10-16 · Conversion · Disposed 8,882 · Balance 0 F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The issuer's preferred stock will automatically convert into issuer's common stock on a one-to-one basis immediately prior to the closing of the issuer's initial public offering and has no expiration date.

F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F4: This reported amount represents the number of shares issuable upon the conversion of the principal and accrued interest of the convertible promissory note held by the reporting person.

F5: The outstanding principal and accrued interest of the reporting person's convertible promissory note automatically converted into shares of the issuer's common stock at the price per share available to the public as set forth in the final prospectus related to the initial public offering upon closing of the initial public offering.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Forty Seven, Inc.

Report date July 02, 2018 · Filed July 03, 2018

Section 16 reporting ended · disclosed 2018-07-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Ltd Partnership (SHV)	2,906,372	Last balance in matching sequence After 2018-07-02 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2018-07-02 · Conversion · Acquired 1,052,146 · Balance 1,052,146 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 2 · 2018-07-02 · Conversion · Acquired 945,326 · Balance 1,997,472 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 3 · 2018-07-02 · Conversion · Acquired 774,165 · Balance 2,771,637 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 4 · 2018-07-02 · Purchase · Acquired 134,735 · Balance 2,906,372 F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Trust	41,305	Last balance in matching sequence After 2018-07-02 transaction · row 8 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 5 · 2018-07-02 · Conversion · Acquired 13,839 · Balance 13,839 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 6 · 2018-07-02 · Conversion · Acquired 13,435 · Balance 27,274 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 7 · 2018-07-02 · Conversion · Acquired 12,116 · Balance 39,390 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein. Row 8 · 2018-07-02 · Purchase · Acquired 1,915 · Balance 41,305 F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2018-07-02 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-07-02 · Conversion · Disposed 1,052,146 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A-2 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2018-07-02 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-07-02 · Conversion · Disposed 774,165 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2018-07-02 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2018-07-02 · Conversion · Disposed 945,326 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F2: Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a managing director and member of the management committee of the general partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A-1 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2018-07-02 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2018-07-02 · Conversion · Disposed 13,839 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series A-2 Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2018-07-02 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2018-07-02 · Conversion · Disposed 12,116 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Series B Preferred StockSEC Table II · derivative / convertible security	IndirectBy Trust	0	Reported balance After 2018-07-02 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2018-07-02 · Conversion · Disposed 13,435 · Balance 0 F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date. F3: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The issuer's preferred stock automatically converted into issuer's common stock on a one-to-one basis immediately upon the closing of the issuer's initial public offering and has no expiration date.

Yext, Inc.

Report date December 01, 2017 · Filed December 05, 2017

Section 16 reporting ended · disclosed 2017-12-05. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy Ltd Liability Company (SHM)	78,140	Reported balance After 2017-12-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2017-12-01 · Other · Acquired 78,140 · Balance 78,140 F1: Represents the receipt of shares in the pro rata distribution described below, for no additional consideration, by Sutter Hill Management Company, L.L.C. ("SHM"), a limited partner of Sutter Hill Ventures, a California Limited Partnership ("SHV"). F2: Shares held by SHM. SHV has voting and dispositive power over the shares held by SHM, and the reporting person is a trustee of a trust which is a member of SHM. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Ltd Partnership (SHV As Nominee)	258,439	Reported balance After 2017-12-01 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2017-12-01 · Other · Acquired 258,439 · Balance 258,439 F3: Represents the retention of shares by SHV, in connection with the distribution described below, for the benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV. F4: Shares held by SHV as a nominee on behalf of, and for the exclusive benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Ltd Partnership (SHV)	0	Reported balance After 2017-12-01 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-12-01 · Other · Disposed 8,614,633 · Balance 0 F5: Effective December 1, 2017, SHV effected a pro rata distribution of 8,614,633 shares of Common Stock to its limited partners and its general partner for no additional consideration, of which 6,460,975 shares were distributed to the limited partners and 2,153,658 shares, representing the general partner's interest in the distribution, were retained by SHV and are now being held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner. SHV has no pecuniary interest in such retained shares. F6: Excludes shares of Common Stock held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner of SHV. F7: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectBy Trust	87,383	Reported balance Holding disclosure · report date 2017-12-01 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 87,383 F8: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the receipt of shares in the pro rata distribution described below, for no additional consideration, by Sutter Hill Management Company, L.L.C. ("SHM"), a limited partner of Sutter Hill Ventures, a California Limited Partnership ("SHV").

F2: Shares held by SHM. SHV has voting and dispositive power over the shares held by SHM, and the reporting person is a trustee of a trust which is a member of SHM. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F3: Represents the retention of shares by SHV, in connection with the distribution described below, for the benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV.

F4: Shares held by SHV as a nominee on behalf of, and for the exclusive benefit of a trust (of which the reporting person is a trustee), which is a member of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F5: Effective December 1, 2017, SHV effected a pro rata distribution of 8,614,633 shares of Common Stock to its limited partners and its general partner for no additional consideration, of which 6,460,975 shares were distributed to the limited partners and 2,153,658 shares, representing the general partner's interest in the distribution, were retained by SHV and are now being held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner. SHV has no pecuniary interest in such retained shares.

F6: Excludes shares of Common Stock held by SHV as a nominee on behalf of, and for the exclusive benefit of, the members of the general partner of SHV.

F7: Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F8: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 07, 2026 Filed Oct 9, 2026 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	661	$376.06	$248,575.66	Disclosure SEC source: 0001484394-26-000014 · form4-10092026_101022.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 2,648 F3 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
October 07, 2026 Filed Oct 9, 2026 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,333	$376.06	$3,133,707.98	Disclosure SEC source: 0001484394-26-000014 · form4-10092026_101022.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 286,400 F3 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
October 07, 2026 Filed Oct 9, 2026 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,505	$376.06	$1,318,090.30	Disclosure SEC source: 0001484394-26-000014 · form4-10092026_101022.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,019 F3 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
October 01, 2026 Filed Oct 9, 2026 22:36 UTC	Astera Labs, Inc. ALAB · Entity 1853	GrantCommon Stock	68	$311.57	$21,186.76	Disclosure SEC source: 0001484394-26-000014 · form4-10092026_101022.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,524 F1 · shares: These shares represent an award of restricted stock units ("RSUs") granted on October 1, 2026, under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan in lieu of cash compensation for quarterly non-employee director retainer fees pursuant to the Reporting Person's election. The award provides that 100% of the RSUs will vest on the three-month anniversary of the Vesting Commencement Date of August 15, 2026, subject to the Reporting Person's continuous service relationship with the Issuer through the applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. F2 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	32	$276.75	$8,856.06	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 12 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 3,309 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.29 to $277.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	407	$276.75	$112,638.06	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 11 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 294,733 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.29 to $277.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	172	$276.75	$47,601.34	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 10 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,456 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.29 to $277.12 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	148	$275.53	$40,778.88	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 9 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 3,341 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.15 to $276.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,867	$275.53	$514,420.11	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 8 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 295,140 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.15 to $276.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	785	$275.53	$216,293.41	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 7 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,628 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.15 to $276.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	429	$274.79	$117,884.48	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 6 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 3,489 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.07 to $275.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,409	$274.79	$1,486,333.70	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 5 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 297,007 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.07 to $275.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,275	$274.79	$625,144.98	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,413 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.07 to $275.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	52	$273.64	$14,229.44	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 3,918 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.27 to $274.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	650	$273.64	$177,867.95	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 302,416 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.27 to $274.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
September 02, 2026 Filed Sep 3, 2026 23:07 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	273	$273.64	$74,704.54	Disclosure SEC source: 0001484394-26-000011 · form4-09032026_110939.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,688 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.27 to $274.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	416	$313.07	$130,238.78	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 9 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 3,970 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.41 to $313.211 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	5,246	$313.07	$1,642,386.20	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 8 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 303,066 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.41 to $313.211 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,207	$313.07	$690,954.32	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 7 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,961 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.41 to $313.211 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	51	$311.37	$15,879.97	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 6 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 4,386 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.20 to $312.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	640	$311.37	$199,278.08	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 5 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 308,312 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.20 to $312.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	269	$311.37	$83,759.07	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,168 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $311.20 to $312.02 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	194	$309.29	$60,002.07	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 4,437 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.67 to $309.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	2,447	$309.29	$756,830.18	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 308,952 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.67 to $309.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 06, 2026 Filed Aug 10, 2026 20:17 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,029	$309.29	$318,258.38	Disclosure SEC source: 0001484394-26-000009 · form4-08102026_080832.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,437 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.67 to $309.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
July 01, 2026 Filed Jul 2, 2026 23:29 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	661	$450.00	$297,450.00	Disclosure SEC source: 0001484394-26-000006 · form4-07022026_110723.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 4,631 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
July 01, 2026 Filed Jul 2, 2026 23:29 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,333	$450.00	$3,749,850.00	Disclosure SEC source: 0001484394-26-000006 · form4-07022026_110723.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 311,399 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F3 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
July 01, 2026 Filed Jul 2, 2026 23:29 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,505	$450.00	$1,577,250.00	Disclosure SEC source: 0001484394-26-000006 · form4-07022026_110723.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,466 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
June 04, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	GrantCommon Stock	837	$0.00	$0.00	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 7 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,971 F7 · shares: These shares represent an award of restricted stock units (RSUs) granted on June 4, 2026 (the Grant Date) under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award vests in full upon the earlier of (i) the first anniversary of the Grant Date or (ii) the date of the next annual stockholder meeting of the Issuer following the Grant Date, subject to the Reporting Person's continuous service relationship with the Issuer through such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	81	$365.09	$29,572.05	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 6 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 5,292 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,019	$365.09	$372,023.65	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 5 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 319,732 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	428	$365.09	$156,257.24	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,134 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $365.00 to $365.49 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	580	$364.25	$211,262.68	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 5,373 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.395 to $364.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,314	$364.25	$2,664,095.24	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 320,751 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.395 to $364.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
June 03, 2026 Filed Jun 5, 2026 21:09 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,077	$364.25	$1,120,784.94	Disclosure SEC source: 0001484394-26-000004 · form4-06052026_090646.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,562 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $363.395 to $364.35 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.direct: Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	325	$201.10	$65,358.15	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 6 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 5,953 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,095	$201.10	$823,512.69	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 5 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 328,065 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,722	$201.10	$346,297.64	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,639 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	336	$199.00	$66,864.00	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 6,278 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F3 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	4,238	$199.00	$843,362.00	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 332,160 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
May 07, 2026 Filed May 11, 2026 23:22 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,783	$199.00	$354,817.00	Disclosure SEC source: 0001484394-26-000002 · form4-05112026_110548.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,361 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	709	$175.12	$124,160.08	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 6 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 6,614 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.02 to $175.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	8,933	$175.12	$1,564,346.96	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 5 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 336,398 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.02 to $175.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
April 20, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,757	$175.12	$657,925.84	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 4 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,144 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.02 to $175.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
April 17, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	613	$175.00	$107,275.00	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 3 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 7,323 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
April 17, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	7,733	$175.00	$1,353,275.00	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 2 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 345,331 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
April 17, 2026 Filed Apr 21, 2026 20:19 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	3,253	$175.00	$569,275.00	Disclosure SEC source: 0001231919-26-000382 · form4-04212026_080414.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,901 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.00 to $175.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
August 13, 2025 Filed Aug 15, 2025 22:21 UTC	Astera Labs, Inc. ALAB · Entity 1853	GiftCommon Stock	11,000	$0.00	$0.00	Disclosure SEC source: 0001415889-25-022112 · form4-08152025_100806.xml · nonDerivative · entry 1 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 353,064 F1 · ownership.nature: Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 08, 2025 Filed Aug 11, 2025 23:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	1,000	$175.26	$175,259.10	Disclosure SEC source: 0001415889-25-021461 · form4-08112025_110822.xml · nonDerivative · entry 8 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Limited Partnership (TF) Disclosed balance after: 7,936 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.07 to $175.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. Read SEC document
August 08, 2025 Filed Aug 11, 2025 23:37 UTC	Astera Labs, Inc. ALAB · Entity 1853	SaleCommon Stock	25,000	$175.26	$4,381,477.50	Disclosure SEC source: 0001415889-25-021461 · form4-08112025_110822.xml · nonDerivative · entry 7 Dyckerhoff Stefan A · CIK 0001484394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,154 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.07 to $175.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 2,351 shares to be issued in connection with the vesting of restricted stock units. The Reporting Person shares pecuniary interest in such shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.